7
Total investments
5
Early stage
2
Mid stage
0
Late stage
8y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor, Investor
May 2022
The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases.
ResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.
Advisor, Investor
Sep 2020
Aluna is designed to help you understand your chronic respiratory condition (such as asthma) and allow you to take control of your lung health. Using a combination of machine learning, our spirometer device and mobile app, you can now use the daily measurements to help you understand and manage your asthma.
Advisor, Investor
Mar 2019
Make weather-related decisions in time to matter. Reliable, award-winning 2- to 52-week forecasts for adapting to a more volatile climate.
Investor
Dec 2018
Plex has developed a novel AI-driven analytical platform for scientists that puts the underlying scientific data front-and-center -- transparently -- for scientists to see. Plex answers complex drug discovery questions by identifying the convergence of data across far-flung, disparate raw data sources. Plex pieces together clues and hidden connections from massive amounts of data including small molecule bioactivities, gene expression profiles, genomics, proteomics, metabolomics, perturb seq data, clinical trial information, and much more.
Plex works with biotech and pharma companies to address critical questions in drug discovery and development, including target ID/validation, target discovery, disease indication discovery/expansion, biomarker discovery/validation, safety assessment, and precision oncology.
Board Member
Oct 2018
Women founded in 2014 out of the MIT media lab, sustainable Soofa Signs are the leading solar powered communication tool for cities and advertisers. Currently, Soofa Signs have homes in over 57 cities across the U.S with plans to expand.
Soofa advertisers are guaranteed high traffic, unique locations, countless ways to measure success, and a platform to update messaging in real time. We’ve worked with brands large and small like Blue Man Group, RedBull, New England Revolution, and Wayfair, proving that more businesses are emphasizing sustainable advertising practices.
Additionally, cities like Boston, Atlanta, and Miami utilize Soofa Signs to create unique and engaging messaging with their communities thanks to our neighborhood news feed. If it’s an urgent message, or one just for fun, Soofa Signs make it easy to get information to your intended audience.
Overall, we are a passionate team of engineers, designers, and problem-solvers, located in Cambridge, MA and other cities across the world. We believe in what we do, and we’re excited about creating impactful experiences that change the way we live in cities.
Learn more about Soofa by visiting our website!
Advisor, Investor
Apr 2018
Droplette is a technology company revolutionizing the skincare industry with its breakthrough device. We are driven by the belief that technology has the power to improve health and wellness, and we are dedicated to creating products and solutions that improve upon the way things have always been done, starting with skincare.
Traditional topicals can only do so much. The Droplette device and capsules use our enhanced aerosol technology to deliver active ingredients under the skin - where they can actually work.
Droplette was founded in 2017 by two MIT-trained engineers. Over the past 3 years, we have developed the technology and formulations that address consumers’ most common skin concerns. Today, we are a diverse set of domain experts--ranging from engineers and biologists, to dermatologists and skincare industry veterans-- dedicated to helping our customers achieve their skin care goals. #dropletteskin
Investor
Feb 2018
Welcome to Fi.
We’re a passionate team of alumni from Square, Google, Peloton, Uber, and more working to transform the dog-human relationship. Our mission? Develop cutting-edge tech to revolutionize what it means to be a dog parent.
The dog industry remains firmly stuck in the past, but were not satisfied with the status quo. Fi is leveraging our teams talent and expertise to improve the lives of 100 million+ dogs in the U.S. Real-time location tracking, activity and step counting, sleep and behavior monitoring – and thats just the beginning.
The most exciting aspect of our work? Bridging the communication gap between dogs and humans. Imagine a world where your pet can tell you when something feels off. Thats the future were building at Fi.
Join us in our pursuit of the “impossible,” which really means “let me find a way,” to redefine the future of dog ownership together.
Experience · 9 entries
All (9)
Investments (7)
Founder (1)
Board (1)
2022
Advisor, Investor
May 2022
The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases.
ResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.
2021
VP - New Ventures
Aug 2021
Toast empowers restaurants of all sizes to build great teams, increase revenue, improve operations, and delight guests.
We pair our deep understanding of the restaurant industry with powerful cloud based software and restaurant-grade hardware to deliver an intuitive, all-in-one platform, across point of sale, guest marketing, digital ordering & delivery, and payroll & HR
We are Toasters! Think you could be one too? https://careers.toasttab.com/
2020
Advisor, Investor
Sep 2020
Aluna is designed to help you understand your chronic respiratory condition (such as asthma) and allow you to take control of your lung health. Using a combination of machine learning, our spirometer device and mobile app, you can now use the daily measurements to help you understand and manage your asthma.
2019
Advisor, Investor
Mar 2019
Make weather-related decisions in time to matter. Reliable, award-winning 2- to 52-week forecasts for adapting to a more volatile climate.
2018
Investor
Dec 2018
Plex has developed a novel AI-driven analytical platform for scientists that puts the underlying scientific data front-and-center -- transparently -- for scientists to see. Plex answers complex drug discovery questions by identifying the convergence of data across far-flung, disparate raw data sources. Plex pieces together clues and hidden connections from massive amounts of data including small molecule bioactivities, gene expression profiles, genomics, proteomics, metabolomics, perturb seq data, clinical trial information, and much more.
Plex works with biotech and pharma companies to address critical questions in drug discovery and development, including target ID/validation, target discovery, disease indication discovery/expansion, biomarker discovery/validation, safety assessment, and precision oncology.
Show all 9 entries ↓
Investment activity
2018–2022 · 7 investments
Recent (last 2 years)Earlier
